Programmes Opioids Clinical Primer Ressources Slow-release oral morphine as opioid agonist therapy: Plain language summary
Certains contenus peuvent être disponibles uniquement en anglais.
Slow-release oral morphine as opioid agonist therapy: Plain language summary

Slow-release oral morphine as opioid agonist therapy: Plain language summary

Evidence, Guidelines and Recommendations

A summary of the recommendations, intended for patients interested in learning about SROM as OAT.

Détails

Catégorie
Evidence, Guidelines and Recommendations
Format
Document PDF
Taille du fichier
0.09 MB
Téléchargements
0
Ajouté
25 août 2025
Tags
Psychiatrie
Douleur
Santé mentale
Troubles liés à l'usage de substances
Soins primaires
Médecine interne
Médecine d’urgence

Ressources connexes

Canadian Guideline for Opioids for Chronic Non-Cancer Pain
The Canadian Guideline for Opioid for Chronic Non-Cancer Pain was developed in response to concerns that Canadians are the second highest users per capita of opioids in the world, while the rates of opioid prescribing and opioid-related hospital visits and deaths have been increasing rapidly.
Opioid Wisely
Find 15 specialty-specific recommendations for when the use of opioids should not be first line therapy and information resources to help patients have informed conversations with their clinicians about safe options for managing pain.
Recommendations for the use of slow-release oral morphine as opioid agonist therapy
Bringing together published evidence and both clinical and experiential expertise, these recommendations are intended to guide prescribers in the use of slow-release oral morphine (SROM, brand name Kadian) as opioid agonist therapy (OAT).

En savoir plus

Restez informé

Actualités et mises à jour directement dans votre boîte de réception.

© 2025 McMaster University et autres | 1280, rue Main Ouest | Hamilton, Ontario L8S 4L8 | Conditions d'utilisation